The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced obesity-associated breast cancer growth in a mouse model, according to a study being ...

Scientists at Oregon Health & Science University have developed a new molecule that could open the door to treating triple-negative breast cancer, one of the most aggressive and difficult-to-treat ...

Anti-diabetic and obesity drug, tirzepatide, also known as Mounjaro and Zepbound, induced weight loss in obese mice and reduced growth of breast cancer tumors. The corresponding study was presented at ...

SPRING, Texas, March 11, 2026 (GLOBE NEWSWIRE) -- Io Therapeutics, Inc. in Spring, Texas, announces collaborative publication of data from preclinical studies with scientists at The University of ...

An enigmatic type of circulating tumor cell called a dual-positive (DP) cell is associated with shorter survival time in patients with advanced breast cancer, according to a study led by investigators ...

A next-generation cancer vaccine has shown stunning results in mice, preventing up to 88% of aggressive and difficult-to-treat cancers by harnessing dual-pathway nanoparticles that train the immune ...

A microbe involved in gum disease could fan the flames of breast cancer. In mice, the oral bacterium can swell the size of existing tumors and even spark the formation of precancerous growths, ...

By Hugo Francisco de Souza A large NHS screening study shows that artificial intelligence can detect subtle signals in ...